Skip to main content
. 2015 Apr 8;9(6):TC01–TC04. doi: 10.7860/JCDR/2015/13514.6026

[Table/Fig-2]:

List and number of malignant cases

Histology (Malignant Lesions) No. of Cases
SCCA 7(43%)
Adenocarcinoma 2(12%)
Lymphoma 4(25%)
Rhabdomyosarcoma 1(6%)
Esthesioneuroblastoma 1(6%)
Malignant melanoma 1(6%)